Publications

Strategies to enhance the distribution of nanotherapeutics in the brain.
J Control Release 2017 Dec 21;267:232-239. Epub 2017 Jul 21.
Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, United States; Department of Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, United States. Electronic address:

mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma.
Dev Cell 2017 Dec 2;43(6):673-688.e5. Epub 2017 Nov 2.
Department of Developmental Neurobiology, Neurobiology and Brain Tumor Program, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA. Electronic address:




The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity.
Neuro Oncol 2017 Oct;19(10):1361-1371
Division of Neuropathology and Sidney Kimmel Comprehensive Cancer Center and Division of Pediatric Oncology and Bloomberg Children's Hospital, Johns Hopkins Hospital, Baltimore, Maryland; St Jude Children's Research Hospital, Memphis, Tennessee.

Melanoma subtypes demonstrate distinct PD-L1 expression profiles.
Lab Invest 2017 Sep 24;97(9):1063-1071. Epub 2017 Jul 24.
Department of Dermatology, Johns Hopkins University School of Medicine, Bloomberg Kimmel Institute for Cancer Immunotherapy, and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.

The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma.
Cancer Lett 2017 Aug 25;400:110-116. Epub 2017 Apr 25.
Department of Pathology, Division of Neuropathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:

Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, andHybridization.
Clin Cancer Res 2017 Jun 29;23(12):3150-3157. Epub 2016 Dec 29.
Department of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Cancer Cell 2017 Jun;31(6):737-754.e6
The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada; Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A1, Canada; Division of Neurosurgery, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada. Electronic address:


Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.
J Clin Oncol 2016 Jul 6;34(21):2468-77. Epub 2016 Jun 6.
Vijay Ramaswamy, Stephen C. Mack, Alvaro Lassaletta, Betty Luu, Florence M.G. Cavalli, Uri Tabori, Ute Bartels, Eric Bouffet, Cynthia E. Hawkins, James T. Rutka, Peter Dirks, and Michael D. Taylor, The Hospital for Sick Children; Vijay Ramaswamy, Kenneth Aldape, James T. Rutka, and Michael D. Taylor, University of Toronto; Kenneth Aldape, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario; Christopher Dunham and Juliette Hukin, British Columbia Children's Hospital; Juliette Hukin, University of British Columbia, Vancouver, British Columbia; David D. Eisenstat, Dorcas Fulton, and Frank K.H. van Landeghem, University of Alberta, Edmonton; Jennifer A. Chan, University of Calgary, Calgary, Alberta; Nada Jabado and Kevin Petrecca, McGill University, Montreal, Quebec, Canada; Thomas Hielscher, Kristian W. Pajtler, David T.W. Jones, Marcel Kool, Stefan M. Pfister, and Andrey Korshunov, German Cancer Research Center; Stefan M. Pfister, University Hospital Heidelberg, Heidelberg; Marc Remke, University Hospital Düsseldorf, Düsseldorf; Martin Mynarek, Stefan Rutkowski, and Katja von Hoff, University Medical Center Hamburg-Eppendorf, Hamburg; Ulrich Schüller, Ludwig-Maximilians-Universität, Munich, Germany; Stephen C. Mack, Cleveland Clinic Foundation, Cleveland; Maryam Fouladi, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Tong Lin, Amar Gajjar, Thomas E. Merchant, and David W. Ellison, St Jude Children's Research Hospital, Memphis; Lola B. Chambless, Vanderbilt Medical Center, Nashville, TN; Sridharan Gururangan, Roger E. McLendon, and Eric S. Lipp, Duke University, Durham; Jing Wu, University of North Carolina at Chapel Hill, Chapel Hill, NC; Mariarita Santi, Children's Hospital of Philadelphia; Lyndsey Emery, Hospital of the University of Pennsylvania, Philadelphia; Ronald L. Hamilton and Ian F. Pollack, University of Pittsburgh School of Medicine; Frank Lieberman, University of Pittsburgh Medical Cen

Somatic mutations of DICER1 and KMT2D are frequent in intraocular medulloepitheliomas.
Genes Chromosomes Cancer 2016 May 4;55(5):418-27. Epub 2016 Feb 4.
Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), and Department of Neuropathology University Hospital, Heidelberg, Germany.


Divergent clonal selection dominates medulloblastoma at recurrence.
Nature 2016 Jan 13;529(7586):351-7. Epub 2016 Jan 13.
Developmental &Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario M5G 0A4, Canada.



Clinicopathologic implications of NF1 gene alterations in diffuse gliomas.
Hum Pathol 2015 Sep 30;46(9):1323-30. Epub 2015 May 30.
Division of Neuropathology, Johns Hopkins University School of Medicine, 1800 Orleans Street, Baltimore, MD 21231; Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1800 Orleans Street, Baltimore, MD 21231. Electronic address:

Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.
J Neuropathol Exp Neurol 2015 Sep;74(9):889-900
From the Division of Neuropathology, Department of Pathology, Johns Hopkins Hospital (UDK, MN, CGE); and Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University (MH), Baltimore, Maryland; Anatomical Pathology, St Jude Children Research Hospital, Memphis, Tennessee (BAO); and Department of Neurosurgery, University Medical Center Düsseldorf, Düsseldorf, Germany (UDK, AKS, KK, JM).

Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition.
J Neuropathol Exp Neurol 2015 Aug;74(8):778-90
From the Division of Neuropathology and Sidney Kimmel Comprehensive Cancer Center (ICT, MH-C, WB, CGE, EHR) and Division of Pediatric Oncology (ICT, EHR), Johns Hopkins University, Bloomberg Children's Hospital, Baltimore, Maryland; Children's National Medical Center and George Washington University School of Medicine and Health Sciences, Washington, District of Columbia (MK, JN); Department of Neurology and Ophthalmology, Michigan State University, East Lansing (HTC); and Sparrow Health System, Lansing (HTC), Michigan; and Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (KEW).

Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis.
Neurology 2015 May 18;84(19):1948-55. Epub 2015 Feb 18.
From the Departments of Neurology (D.G., T.W., N.K., A.H., A.C., A.R., N.B., J.L.B., R.J.C., R.M., M.A.N.), Microbiology (D.G., R.J.C.), Pathology (P.J.B., B.K.), and Ophthalmology (J.L.B., N.M.), University of Colorado School of Medicine, Aurora; Children's Hospital (C.G., J.E.C.), University of Iowa, Iowa City; Arapahoe County Coroner's Office (K.L.-K.), Aurora, CO; Denver Office of the Medical Examiner (D.B.H.), Denver, CO; Department of Pathology (C.G.E.), Johns Hopkins University School of Medicine, Baltimore, MD; A.M. Rywlin Department of Pathology (B.B., R.J.P.), Mount Sinai Medical Center, Miami Beach, FL; Florida International University (B.B., R.J.P.), Miami Beach; Scheie Eye Institute (M.A.T.) and Department of Pathology and Laboratory Medicine (F.F.), University of Pennsylvania, Philadelphia; Texas Oculoplastic Consultants (M.A., E.W., V.D.), Austin; University of Texas, Southwestern - Austin Transitional Year Program (E.W.), Austin; Departments of Pathology and Laboratory Medicine, Ophthalmology, and Visual Sciences (S.R.), University of British Columbia, Vancouver, Canada; Landspitali University Hospital (V.P.), Reykjavik, Iceland; Department of Neurology (L.P.) and Pathological Institute (S.M.), Assaf Harofeh Medical Center, Zerifin, University of Tel Aviv, Israel; Department of Pathology (D.C.), Centre Hospitalier Universitaire du Nord and RECIP, Amiens, France; Institute of Neuropathology (K.K.), University of Duisburg-Essen, Germany; and Department of Neuropathology (W.B.), University Medical Center Gottingen, Germany.

Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma.
Brain Pathol 2015 Mar 21;25(2):193-201. Epub 2014 May 21.
Department of Pathology, Johns Hopkins University, Baltimore, MD; Division of Pathology, Children's National Medical Center, Washington, DC.

Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats.
J Control Release 2015 Mar 8;201:32-40. Epub 2015 Jan 8.
Department of Ophthalmology, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, 400 North Broadway, Baltimore, MD 21231, USA; Center for Nanomedicine, The Johns Hopkins University School of Medicine, 400 North Broadway, Baltimore, MD 21231, USA; Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, 3400 North Charles Street, Baltimore, MD 21218, USA. Electronic address:

Notch signaling activation in pediatric low-grade astrocytoma.
J Neuropathol Exp Neurol 2015 Feb;74(2):121-31
From the Departments of Pathology (WDB, KCS, IT, ER, CGE, FJR), Neuroscience (KCS, EEB), and Oncology (LM, ER, CGE, FJR), Johns Hopkins University, Baltimore, Maryland; and Department of Neurological Surgery, Case Western Reserve University, Cleveland, Ohio (EEB).

The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity.
J Neuropathol Exp Neurol 2015 Feb;74(2):177-85
From the Division of Neuropathology and Sidney Kimmel Comprehensive Cancer Center (HK, MH-C, MFW, CGE, EHR), Division of Pediatric Oncology (EHR), Johns Hopkins University School of Medicine, Bloomberg Children's Hospital, Baltimore, Maryland; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina (YK, BEW); and Division of Hematology, Oncology, and Blood and Bone Marrow Transplant, Children's Hospital Los Angeles (JX, AE-E); and the University of Southern California (AE-E), Los Angeles, California.


Mass confusion in a 30-year-old man.
J Neuroophthalmol 2014 Dec;34(4):408-11
Department of Ophthalmology and Visual Sciences (EM, JG), University of Toronto, Toronto, Canada; Department of Neurology (EM), University of Toronto, Toronto, Canada; Department of Ophthalmology (JG), Queen Elizabeth Hospital, Bridgetown, Barbados; and Departments of Pathology (CGE) and Radiology and Radiological Science (AMB), Johns Hopkins Medical Center, Baltimore, Maryland.

Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinoma.
Invest Ophthalmol Vis Sci 2014 Dec 9;55(12):8604-13. Epub 2014 Dec 9.
Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, Maryland, United States Department of Ophthalmology, Johns Hopkins University, School of Medicine, Baltimore, Maryland, United States Department of Oncology, Johns Hopkins University, School of Medicine, Baltimore, Maryland, United States.


Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas.
Neuro Oncol 2014 Oct 6;16(10):1408-16. Epub 2014 May 6.
NYU Comprehensive Neurofibromatosis Center, Division of Pediatric Hematology/Oncology, Department of Pediatrics and Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York (M.A.K., G.L., A.M., J.C.A.); Division of Oncology, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania (M.J.F., A.J.S.); Department of Radiology, NYU Langone Medical Center, New York, New York (S.S.M., M.C.B.); The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland (K.J.C.); Division of Pediatric Neurosurgery, Department of Neurosurgery, NYU Langone Medical Center, New York, New York (J.H.W., D.H.H.); Division of Biostatistics, Department of Population Health and The Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York (J.D.G., T.H.); Department of Neurosurgery, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania (A.C.R); Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California (G.D.); German Cancer Research Center and University Hospital, Heidelberg, Germany (D.T.W.J., A.K., S.M.P.); Division of Neuropathology, Department of Pathology, Johns Hopkins University, Baltimore, Maryland (C.G.E.); Division of Neuropathology, Department of Pathology, Department of Neurosurgery and Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York (D.Z.).


The demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanoma.
Invest Ophthalmol Vis Sci 2014 Aug 21;55(10):6178-86. Epub 2014 Aug 21.
Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.

HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells.
Cancer Res 2014 Jun 7;74(11):3168-79. Epub 2014 Apr 7.
Authors' Affiliations: Hugo W. Moser Research Institute at Kennedy Krieger; Departments of Neurology, Neuroscience, Oncology, Neurosurgery, and Pathology, Johns Hopkins School of Medicine; Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; and Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GeorgiaAuthors' Affiliations: Hugo W. Moser Research Institute at Kennedy Krieger; Departments of Neurology, Neuroscience, Oncology, Neurosurgery, and Pathology, Johns Hopkins School of Medicine; Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; and Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia


Long interspersed element-1 protein expression is a hallmark of many human cancers.
Am J Pathol 2014 May 6;184(5):1280-6. Epub 2014 Mar 6.
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland; High Throughput Biology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address:

DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.
Am J Ophthalmol 2014 Mar 7;157(3):640-7.e1-2. Epub 2013 Dec 7.
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Ophthalmology, Johns Hopkins University School of Medicine Wilmer Eye Institute, Baltimore, Maryland. Electronic address:

Cytogenetic prognostication within medulloblastoma subgroups.
J Clin Oncol 2014 Mar 3;32(9):886-96. Epub 2014 Feb 3.
David J.H. Shih, Marc Remke, Vijay Ramaswamy, Betty Luu, Yuan Yao, Xin Wang, Adrian M. Dubuc, Livia Garzia, John Peacock, Stephen C. Mack, Xiaochong Wu, Adi Rolider, A. Sorana Morrissy, Florence M.G. Cavalli, Claudia C. Faria, Stephen W. Scherer, Uri Tabori, Cynthia E. Hawkins, David Malkin, Eric Bouffet, James T. Rutka, and Michael D. Taylor, Hospital for Sick Children; David J.H. Shih, Marc Remke, Vijay Ramaswamy, Yuan Yao, Xin Wang, Adrian M. Dubuc, John Peacock, Stephen C. Mack, and Michael D. Taylor, University of Toronto, Toronto; Boleslaw Lach, McMaster University, Hamilton, Ontario; Jennifer A. Chan, University of Calgary, Calgary, Alberta; Steffen Albrecht, Adam Fontebasso, and Nada Jabado, McGill University, Montreal, Quebec, Canada; Paul A. Northcott, Andrey Korshunov, Marcel Kool, David T.W. Jones, and Stefan M. Pfister, German Cancer Research Center; Stefan M. Pfister, University Hospital Heidelberg, Heidelberg; Ulrich Schüller, Ludwig-Maximilians-University, Munich; Stefan Rutkowski, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Karel Zitterbart, Masaryk University School of Medicine; Karel Zitterbart and Leos Kren, University Hospital Brno, Brno, Czech Republic; Toshihiro Kumabe and Teiji Tominaga, Tohoku University Graduate School of Medicine, Sendai, Japan; Young Shin Ra, University of Ulsan, Asan Medical Center; Ji-Yeoun Lee, Byung-Kyu Cho, Seung-Ki Kim, and Kyu-Chang Wang, Seoul National University Children's Hospital, Seoul; Shin Jung, Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital and Medical School, Chonnam, South Korea; Peter Hauser and Miklós Garami, Semmelweis University, Budapest; László Bognár and Almos Klekner, University of Debrecen, Medical and Health Science Centre, Debrecen, Hungary; Shenandoah Robinson, Boston Children's Hospital; Scott L. Pomeroy, Harvard Medical School, Boston, MA; Ali G. Saad, University of Arkansas for Medical Sciences, Little

Design and analysis of keratoconus tissue microarrays.
Cornea 2014 Jan;33(1):49-55
*The Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD; †Department of Ophthalmology, Medical University of Graz, Graz, Austria; ‡Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; §Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD; and ¶Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD.

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.
Acta Neuropathol 2013 Dec 31;126(6):917-29. Epub 2013 Oct 31.
The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.

Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target.
Neuro Oncol 2013 Dec 6;15(12):1604-14. Epub 2013 Nov 6.
Corresponding Authors: Fausto J. Rodriguez, MD, Division of Neuropathology, Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD 21231. Eric H. Raabe, MD, PhD, Division of Neuropathology, Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD 21231

Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.
J Magn Reson Imaging 2013 Nov 25;38(5):1119-28. Epub 2013 Feb 25.
Department of Radiology, Johns Hopkins University, Baltimore, Maryland, USA; F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.



Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas.
Am J Surg Pathol 2013 Sep;37(9):1357-64
*Laboratory of Pathology †Pediatric Oncology Branch, NCI, NIH, Bethesda ‡Department of Pathology, Division of Neuropathology, Johns Hopkins Hospital, Baltimore, MD §Children's National Medical Center, Research Center for Genetic Medicine, Washington, DC.

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.
Nat Genet 2013 Aug 30;45(8):927-32. Epub 2013 Jun 30.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.







Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
PLoS One 2013 16;8(10):e75945. Epub 2013 Oct 16.
Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America ; Johns Hopkins Physical Science Oncology Center and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland, United States of America.


Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation.
PLoS One 2014 28;9(8):e105372. Epub 2014 Aug 28.
Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, Maryland, United States of America; Department of Ophthalmology, Johns Hopkins University, School of Medicine, Baltimore, Maryland, United States of America; Department of Oncology, Johns Hopkins University, School of Medicine, Baltimore, Maryland, United States of America.

EMT-associated factors promote invasive properties of uveal melanoma cells.
Mol Vis 2015 25;21:919-29. Epub 2015 Aug 25.
Department of Pathology, Johns Hopkins University, School of Medicine, Baltimore, MD ; Department of Ophthalmology, Johns Hopkins University, School of Medicine, Baltimore, MD ; Department of Oncology, Johns Hopkins University, School of Medicine, Baltimore, MD.


The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.
Cancer Lett 2016 07 18;377(1):55-64. Epub 2016 Apr 18.
Division of Neuropathology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA; Division of Pediatric Oncology, Johns Hopkins University, Bloomberg Children's Hospital, Room 11379, 1800 Orleans St, Baltimore, MD 21287, USA. Electronic address:

Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
Eur J Cancer 2017 09 10;83:9-18. Epub 2017 Jul 10.
Department of Radiology, Johns Hopkins University, Baltimore, MD, USA; F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, USA. Electronic address:

OF